What is the Suraksha Diagnostic Ltd share price today?

The share price of NSE:SURAKSHA-EQ on 01 Oct 2026 (as of 15:05:00 IST) is ₹349.5.

What is the NSE:SURAKSHA-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SURAKSHA-EQ 52 week high low range shows a high of ₹360 and a low of ₹224.1.

What is the Suraksha Diagnostic Ltd market cap?

As on 01 Oct 2026, Suraksha Diagnostic Ltd market cap is ₹18509500000.

What is the shareholding pattern of Suraksha Diagnostic Ltd Stock?

The shareholding pattern of Suraksha Diagnostic Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 49.1% Foreign Institutional Investors (FII): 13.47% Domestic Institutional Investors (DII): 3.17% Mutual Funds: 20.05% Retail & Others: 14.21% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Suraksha Diagnostic Ltd?

The Price-to-Earnings (PE) ratio of Suraksha Diagnostic Ltd is 51.7069, and the Price-to-Book (PB) ratio is 4.8719, as on 01 Oct 2026.

Suraksha Diagnostic Share Price

310.45-7.85 (-2.47%)

+6.59% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-2.47%

1 Week

-1.83%

1 Month

-3.90%

3 Month

+19.86%

6 Month

+9.87%

YTD

+15.13%

1 Year

+6.59%

5 Year

10 Year

Max

-29.12%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

310.00

304.00

300.00

240.40

224.10

High

319.00

330.75

360.00

About

Suraksha Diagnostic offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services. In addition to Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MANIPALHOSNSE

MAXHEALTHNSE

ASTERDMNSE

FORTISNSE

NHNSE

MEDANTANSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

SURAKSHANSE

LTP

1W Low

1W High

Market cap (₹)

7900.5-127 (-1.58%)

7688

8100

1,12,296Cr

645.6-55.7 (-7.94%)

638.10

707.05

85,493Cr

864.6-19.2 (-2.17%)

842.05

894.80

83,023Cr

691.15-8.7 (-1.24%)

673.30

706.30

58,873Cr

747.2-39.05 (-4.97%)

737.95

785.55

56,577Cr

1731.7+12.2 (0.71%)

1663.50

1735

34,527Cr

1295.6-17.1 (-1.30%)

1257.50

1322.10

34,407Cr

1869-64.6 (-3.34%)

1868

2002.50

32,511Cr

687.85-17.65 (-2.50%)

685.15

718.20

29,188Cr

468.15-9.6 (-2.01%)

463.35

480.95

14,838Cr

310.45-5.8 (-1.83%)

304

330.75

1,654Cr

Suraksha Diagnostic Share Price

310.45-7.85 (-2.47%)

+6.59% past 1 Year

Open a free Demat account in minutes to start investing and screening .

Suraksha Diagnostic Share Price

310.45-7.85 (-2.47%)

+6.59% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years17%

3 years18%

Last year23%

Compounded Profit Growth

10 years-

5 years38%

3 years70%

Last year1%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year9%

Return on Equity

10 years13%

5 years13%

3 years15%

Last year14%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	17%	18%	23%
-	38%	70%	1%
-	-	-	9%
13%	13%	15%	14%

Peer Comparison

Symbol

APOLLOHOSP

MANIPALHOS

MAXHEALTH

ASTERDM

FORTIS

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

SURAKSHA

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
7,900.5	₹112296 Cr	53.74	40.39	207.67	₹1942 Cr
645.6	₹85493 Cr	95.81	1.96	11.95	₹892 Cr
864.6	₹83023 Cr	56.99	3.31	19.84	₹1442 Cr
691.15	₹58873 Cr	184.74	0.31	6.76	₹388 Cr
747.2	₹56577 Cr	53.99	3.53	20.1	₹1042 Cr
1,731.7	₹34527 Cr	42.31	10.14	65.36	₹806 Cr
1,295.6	₹34407 Cr	61.86	5.91	29.85	₹556 Cr
1,869	₹32511 Cr	59.99	10.11	42.51	₹505 Cr
687.85	₹29188 Cr	142.87	1.04	12.74	₹241 Cr
468.15	₹14838 Cr	100.01	1.43	13.88	₹133 Cr
310.45	₹1654 Cr	46.21	2.5	15.18	₹32 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
₹88 Cr	₹81 Cr	₹78 Cr	₹79 Cr	₹73 Cr	₹65 Cr	₹60 Cr	₹67 Cr	₹61 Cr	₹55 Cr	₹52 Cr	₹60 Cr
₹1 Cr	₹79 L	₹62 L	₹85 L	₹91 L	₹82 L	₹60 L	₹1 Cr	₹1 Cr	₹98 L	₹85 L	₹56 L
₹89 Cr	₹82 Cr	₹78 Cr	₹80 Cr	₹73 Cr	₹66 Cr	₹60 Cr	₹68 Cr	₹62 Cr	₹56 Cr	₹53 Cr	₹61 Cr
₹68 Cr	₹68 Cr	₹65 Cr	₹65 Cr	₹58 Cr	₹55 Cr	₹50 Cr	₹52 Cr	₹49 Cr	₹44 Cr	₹44 Cr	₹47 Cr
₹32 Cr	₹25 Cr	₹24 Cr	₹25 Cr	₹25 Cr	₹20 Cr	₹19 Cr	₹25 Cr	₹22 Cr	₹20 Cr	₹16 Cr	₹21 Cr
₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr
₹17 Cr	₹10 Cr	₹10 Cr	₹12 Cr	₹12 Cr	₹9 Cr	₹8 Cr	₹14 Cr	₹11 Cr	₹9 Cr	₹6 Cr	₹11 Cr
₹13 Cr	₹6 Cr	₹7 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹6 Cr	₹10 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹8 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2016	Mar 2015
—	—	—	—	—	—	—	—	—
₹10 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr
₹1 Cr	₹21 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹233 Cr	₹201 Cr	₹171 Cr	₹147 Cr	₹141 Cr	₹118 Cr	₹111 Cr	₹47 Cr	₹41 Cr
₹233 Cr	₹201 Cr	₹171 Cr	₹147 Cr	₹141 Cr	₹118 Cr	₹111 Cr	₹47 Cr	₹41 Cr
₹245 Cr	₹211 Cr	₹179 Cr	₹156 Cr	₹150 Cr	₹126 Cr	₹120 Cr	₹55 Cr	₹49 Cr
-₹1 Cr	-₹1 Cr	-₹26 L	-₹47 L	₹0	₹0	₹0	₹0	₹0
₹18 L	₹3 Cr	₹5 Cr	₹8 Cr	₹12 Cr	₹9 Cr	₹8 Cr	₹29 Cr	₹19 Cr
₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹0	₹0	₹0
₹8 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹10 Cr	₹10 Cr	₹11 Cr	₹7 Cr	₹5 Cr
₹136 Cr	₹71 Cr	₹70 Cr	₹72 Cr	₹0	₹0	₹0	₹0	₹0
₹83 L	₹1 Cr	₹77 L	₹45 L	₹31 L	₹11 L	₹0	₹1 Cr	₹89 L
₹145 Cr	₹81 Cr	₹82 Cr	₹87 Cr	₹23 Cr	₹20 Cr	₹19 Cr	₹37 Cr	₹25 Cr
—	—	—	—	—	—	—	—	—
₹21 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹13 Cr	₹10 Cr	₹13 Cr
₹39 Cr	₹29 Cr	₹25 Cr	₹24 Cr	₹6 Cr	₹6 Cr	₹21 Cr	₹15 Cr	₹10 Cr
₹0	₹0	₹0	₹0	₹7 Cr	₹7 Cr	₹0	₹4 Cr	₹4 Cr
₹15 L	₹13 L	₹52 L	₹8 L	₹1 Cr	₹30,000	₹0	₹4 Cr	₹2 Cr
₹60 Cr	₹43 Cr	₹39 Cr	₹38 Cr	₹28 Cr	₹25 Cr	₹34 Cr	₹33 Cr	₹30 Cr
₹448 Cr	₹334 Cr	₹300 Cr	₹281 Cr	₹201 Cr	₹171 Cr	₹173 Cr	₹125 Cr	₹104 Cr
₹0	₹0	₹2 Cr	₹69 Cr	₹30 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr
₹2 Cr	₹6 Cr	₹9 Cr	₹14 Cr	₹19 Cr	₹16 Cr	₹12 Cr	₹42 Cr	₹28 Cr
—	—	—	—	—	—	—	—	—
₹453 Cr	₹320 Cr	₹274 Cr	₹226 Cr	₹211 Cr	₹198 Cr	₹194 Cr	₹116 Cr	₹88 Cr
₹138 Cr	₹97 Cr	₹62 Cr	₹31 Cr	₹92 Cr	₹79 Cr	₹67 Cr	₹24 Cr	₹15 Cr
₹315 Cr	₹223 Cr	₹212 Cr	₹195 Cr	₹119 Cr	₹119 Cr	₹128 Cr	₹91 Cr	₹73 Cr
₹35 Cr	₹10 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹86,000	₹38 L	₹10 L	₹10 L
₹0	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹1 L	₹1 L
₹0	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹1 L	₹1 L
₹19 Cr	₹16 Cr	₹14 Cr	₹11 Cr	₹9 Cr	₹0	₹10 Cr	₹7 Cr	₹6 Cr
₹15 Cr	₹36 Cr	₹68 L	₹5 Cr	₹49 Cr	₹25 Cr	₹6 Cr	₹0	₹0
₹386 Cr	₹286 Cr	₹228 Cr	₹213 Cr	₹179 Cr	₹144 Cr	₹145 Cr	₹99 Cr	₹79 Cr
—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹5 Cr	₹5 Cr	₹0	₹0
₹8 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹2 Cr
₹23 Cr	₹14 Cr	₹9 Cr	₹5 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹3 Cr
₹26 Cr	₹20 Cr	₹55 Cr	₹55 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹9 Cr	₹12 Cr
₹3 Cr	₹3 Cr	₹63 L	₹1 Cr	₹3 Cr	₹90 L	₹2 Cr	₹73 L	₹60 L
₹3 Cr	₹2 Cr	₹1 Cr	₹71 L	₹2 Cr	₹6 Cr	₹6 Cr	₹8 Cr	₹7 Cr
₹63 Cr	₹47 Cr	₹72 Cr	₹68 Cr	₹22 Cr	₹27 Cr	₹28 Cr	₹26 Cr	₹25 Cr
₹3 Cr	₹4 Cr	₹33 Cr	₹30 Cr	-₹6 Cr	₹2 Cr	-₹6 Cr	-₹7 Cr	-₹5 Cr
₹448 Cr	₹334 Cr	₹300 Cr	₹281 Cr	₹201 Cr	₹171 Cr	₹173 Cr	₹125 Cr	₹104 Cr
₹47	₹41	₹2,577	₹2,236	₹2,150	₹1,806	₹1,712	₹775	₹696
₹47	₹41	₹2,577	₹2,236	₹2,150	₹1,806	₹1,712	₹775	₹696

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2016	Mar 2015
₹45 Cr	₹41 Cr	₹31 Cr	₹7 Cr	₹33 Cr	₹6 Cr	₹21 Cr	₹10 Cr	₹12 Cr
₹53 Cr	₹43 Cr	₹41 Cr	₹40 Cr	₹16 Cr	₹21 Cr	₹14 Cr	₹12 Cr	₹6 Cr
-₹2 Cr	-₹10 Cr	-₹4 Cr	₹5 Cr	-₹2 Cr	-₹3 Cr	₹3 Cr	-₹6 Cr	₹4 Cr
₹95 Cr	₹74 Cr	₹69 Cr	₹51 Cr	₹47 Cr	₹25 Cr	₹38 Cr	₹16 Cr	₹22 Cr
₹82 Cr	₹63 Cr	₹60 Cr	₹44 Cr	₹42 Cr	₹24 Cr	₹31 Cr	₹13 Cr	₹20 Cr
-₹52 Cr	-₹40 Cr	-₹35 Cr	-₹21 Cr	-₹44 Cr	-₹28 Cr	-₹20 Cr	-₹26 Cr	-₹42 Cr
-₹29 Cr	-₹24 Cr	-₹25 Cr	-₹24 Cr	₹1 Cr	₹3 Cr	-₹10 Cr	₹10 Cr	₹17 Cr
₹97 L	-₹27 L	₹36 L	-₹1 Cr	-₹36 L	-₹99 L	₹1 Cr	-₹3 Cr	-₹6 Cr
₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹12 Cr	₹18 Cr
₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹9 Cr	₹12 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Suraksha Diagnostic Share Price

310.45-7.85 (-2.47%)

+6.59% past 1 Year

Shareholding summary

Promoters

49.1%

FII

13.98%

DII

1.4%

20.16%

Others

15.36%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
49.10%	49.10%	49.10%	49.00%	48.98%	48.88%
13.98%	13.47%	13.46%	13.46%	13.73%	13.95%
1.40%	3.17%	3.35%	3.12%	2.53%	2.79%
20.16%	20.05%	19.79%	19.45%	19.45%	19.58%
15.36%	14.21%	14.30%	14.97%	15.31%	14.80%

Bulk & block deals

Name

Bnp Paribas Financial Markets

Integrated Core Strategies (Asia) Pte. Ltd.

Bnp Paribas Financial Markets

Integrated Core Strategies (Asia) Pte. Ltd.

Aakraya Research Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
27 May 2025	Purchase	10.01 Cr	₹338	2.96 L	Bulk	0.568409	BSE
27 May 2025	Sell	10.01 Cr	₹338	2.96 L	Bulk	0.568409	BSE
27 May 2025	Purchase	10.01 Cr	₹338	2.96 L	Block	0.568409	BSE
27 May 2025	Sell	10.01 Cr	₹338	2.96 L	Block	0.568409	BSE
06 Dec 2024	Purchase	16.38 Cr	₹434.91	3.77 L	Bulk	0.723119	NSE
06 Dec 2024	Sell	16.38 Cr	₹435.05	3.77 L	Bulk	0.723119	NSE

Insider trading & SAST

Client name

Aparajita Chatterjee

Bipul Mittal Huf

Bipul Mittal

Ritu Mittal

Dr Somnath Chatterjee

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
25 Feb 2026	Promoters Immediate Relative	Acquisition	0.017281	0.1	25.81 L	₹286.73	9 K	25 Feb 2026	Market Purchase	52,533	Insider Trading	—	Equity Shares
24 Feb 2026	Promoters Immediate Relative	Acquisition	0.01197	0.08	17.56 L	₹281.63	6.23 K	24 Feb 2026	Market Purchase	43,533	Insider Trading	—	Equity Shares
24 Feb 2026	Promoters Immediate Relative	Acquisition	0.030355	0.07	45.02 L	₹284.76	15.81 K	23 Feb 2026	Market Purchase	37,299	Insider Trading	—	Equity Shares
20 Feb 2026	Promoters Immediate Relative	Acquisition	0.021206	0.04	31.02 L	₹280.86	11.04 K	20 Feb 2026	Market Purchase	21,490	Insider Trading	—	Equity Shares
19 Feb 2026	Promoters Immediate Relative	Acquisition	0.020057	0.02	29.23 L	₹279.82	10.45 K	19 Feb 2026	Market Purchase	10,446	Insider Trading	—	Equity Shares
10 Dec 2025	Promoter Group	Acquisition	0.002775	0.03	3.97 L	₹274.70	1.45 K	09 Dec 2025	Market Purchase	16,720	Insider Trading	—	Equity Shares
10 Dec 2025	Promoters Immediate Relative	Acquisition	0.011137	0.04	15.91 L	₹274.32	5.80 K	09 Dec 2025	Market Purchase	21,060	Insider Trading	—	Equity Shares
29 Sep 2025	Promoter & Director	Acquisition	0.036731	15.93	57.71 L	₹301.69	19.13 K	29 Sep 2025	Market Purchase	82,95,437	Insider Trading	—	Equity Shares
21 Aug 2025	Promoter	Acquisition	0.01	5.08	0	—	8.20 K	14 Aug 2025	Market	26,46,968	SAST	29(2)	—
21 Aug 2025	Promoter	Acquisition	0.01	5.09	0	—	7.80 K	18 Aug 2025	Market	26,54,768	SAST	29(2)	—

Suraksha Diagnostic Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Suraksha Diagnostic Share Price

Suraksha Diagnostic Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Suraksha Diagnostic Share Price

Suraksha Diagnostic Share Price

Oscillators

Moving averages

Suraksha Diagnostic Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Suraksha Diagnostic Share Price

Corporate Actions

Company details

Suraksha Diagnostic Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Suraksha Diagnostic Share Price

News

Suraksha Diagnostic Q4 EBITDA rises with marginal improvement in operating margins YoY

Suraksha Diagnostic reports lower quarterly net profit with higher revenue

Suraksha Diagnostic reports Profit after tax of 6.71 Crores, in the March 2026 quarter

Suraksha Diagnostic informs about resignation of chief financial officer (CFO)

Suraksha Diagnostic Group CFO K S Ravindra Resigns for Personal Reasons, Last Day by May 31, 2026.

Suraksha Diagnostic - Quaterly Results

Suraksha Diagnostic Reports Strong Q3 FY26 Earnings with 30.3% Revenue Growth, 26.1% EBITDA Rise.

Suraksha Diagnostic Q3 FY26 Results: Revenue Up 30.3% YoY, PAT Up 21.0% YoY.

Suraksha Diagnostic reports Profit after tax of 8.14 Crores, in the December 2025 quarter

Suraksha Diagnostic informs about board meeting

Suraksha Diagnostic informs about closure of trading window

Suraksha Diagnostic - Quaterly Results

Suraksha Diagnostic informs about outcome of board meeting

Suraksha Diagnostic reports Profit after tax of 9.36 Crores, in the September 2025 quarter

Suraksha Diagnostic informs about board meeting

Suraksha Diagnostic informs about credit rating migration

Suraksha Diagnostic informs about disclosures

Suraksha Diagnostic submits press release

Suraksha Diagnostic - Quaterly Results

Suraksha Diagnostic reports Profit after tax of 9.85 Crores, in the June 2025 quarter

Suraksha Diagnostic Ltd Share Price Today

Suraksha Diagnostic Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator